Patrick Soon-Shiong

Chairman

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

IBRX

Current role

Chairman, CEO, Board Member

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	ImmunityBio, Inc. (IBRX)	—	$648,826	$110,535	$2,787,828	$8,353,406	$378,503	$14,157	$12,293,255
2024	ImmunityBio, Inc. (IBRX)	Global Chief Scientific and Medical Officer	$625,777	—	$1,797,252	$5,411,074	$372,600	$13,991	$8,220,694
2023	ImmunityBio, Inc. (IBRX)	Global Chief Scientific and Medical Officer	$621,000	$232,875	—	—	—	$11,465	$865,340
2022	ImmunityBio, Inc. (IBRX)	Global Chief Scientific and Medical Officer	$616,962	—	—	$3,159,057	—	$12,232	$3,788,251
2021	ImmunityBio, Inc. (IBRX)	Global Chief Scientific and Medical Officer	$237,692	$45,000	—	$300,571	$210,000	$46,604	$839,867
2020	ImmunityBio, Inc. (IBRX)	Global Chief Scientific and Medical Officer	$523,477	$100,170	—	—	—	$20,367	$644,014
2019	ImmunityBio, Inc. (IBRX)	M.D., FRCS (C), FACS Executive Chairman and Chief Executive Officer (until October 26, 2020)	$320,446	—	—	—	—	$11,200	$331,646
2018	ImmunityBio, Inc. (IBRX)	M.D., FRCS (C), FACS Chairman and Chief Executive Officer	$638,446	$270,300	—	—	—	—	$908,746

No earnings-call appearances or filed executive changes recorded yet.